SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

IMS & AGM

18 Apr 2013 07:00

RNS Number : 6284C
Devro PLC
18 April 2013
 



For immediate release 18 April 2013

 

 

Devro plc

(the "Group")

 

Interim Management Statement and Annual General Meeting

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 January 2013 to date, ahead of its Annual General Meeting to be held at 11.00am. Steve Hannam, Chairman of Devro, will make the following statement on current trading.

 

"Devro's global sales have continued to grow during the period. This has been underpinned by good growth in much of Europe and North America, offset by a slower start in the UK and Australia. Select has begun the year well, particularly in Germany where it continues to make good progress.

 

"The major capital investment programme in the Czech Republic is proceeding as planned, with significant additional volume scheduled to come on stream in the second half of this year in order to support further growth in 2014.

 

"As announced at the time of the 2012 preliminary results, we have now implemented the planned price increases we referred to at that time. Input costs have also risen broadly in line with our expectations.

 

"Manufacturing performance, however, has been held back by lower yields, particularly in the USA, which has restricted product available for sale and impacted unit costs.

 

"We remain confident that the Group will meet the board's expectations for the full year. Whilst profits for the first quarter of the year are below the corresponding period in 2012 due to lower production yields, remedial action has already been taken and, with the benefits of recent price rises, additional volume from extra capacity and a focus on improving production processes, we do expect stronger performance as the year progresses.

 

"Net debt and cash flow are both as expected and the financial position of Devro continues to be strong."

 

Peter Page, Chief Executive, commented "Sales continue to grow in volume and value terms across the Group and our investments in people and infrastructure will ensure we have the necessary capability to take advantage of the significant opportunities that exist."

 

ENDS

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 0207 182 4960

 

Buchanan

Diane Stewart/ Carrie Clement/

Charles Ryland

 

 

 

Tel No: 020 7466 5000/0131 226 6150

www.buchanan.uk.com

 

Notes to Editors

 

FTSE 250 listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from 5 manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £241.1 million and profit before tax (excluding pension interest) of £42.2 million for the year ended 31 December 2012. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUWUCUPWGBM
Date   Source Headline
6th Oct 20157:00 amRNSCompletion of acquisition
6th Aug 20153:51 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSINTERIM RESULTS
27th Jul 20152:53 pmRNSListing Rule 9.6.14(R) Disclosure
10th Jul 20157:00 amRNSAcquisition
9th Jun 201511:43 amRNSHolding(s) in Company
1st Jun 20157:00 amRNSTotal Voting Rights
28th May 20152:44 pmRNSHolding(s) in Company
28th May 20152:41 pmRNSHolding(s) in Company
26th May 20158:16 amRNSBlock Listing Six Monthly Return
7th May 20155:10 pmRNSDirector/PDMR Shareholding
29th Apr 20154:15 pmRNSResult of AGM
29th Apr 20157:00 amRNSTrading Update
27th Mar 20157:00 amRNSChange of Auditor
27th Mar 20157:00 amRNS2014 Annual Report
26th Mar 20154:00 pmRNSDirector/PDMR Shareholding
5th Mar 20153:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20152:34 pmRNSDirector Dealings
3rd Mar 20157:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
3rd Dec 20144:19 pmRNSBlock Listing Six Monthly Return
21st Oct 201411:27 amRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSInterim Management Statement
6th Oct 20141:39 pmRNSHolding(s) in Company
29th Aug 201411:23 amRNSTotal Voting Rights
7th Aug 20149:04 amRNSHolding(s) in Company
1st Aug 20142:38 pmRNSDirector/PDMR Shareholding
30th Jul 20147:00 amRNS2014 Interim Results
19th Jun 201410:03 amRNSHolding(s) in Company
10th Jun 20145:00 pmRNSDirector/PDMR Shareholding
30th May 201411:18 amRNSHolding(s) in Company
30th May 20147:00 amRNSTotal Voting Rights
29th May 201410:13 amRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSBlock Listing Six Monthly Return
16th May 201411:01 amRNSDirector/PDMR Shareholding
15th May 20149:00 amRNSConfirmation of Board Change
13th May 20145:16 pmRNSDirector/PDMR Shareholding
8th May 201411:49 amRNSHolding(s) in Company
7th May 20147:00 amRNSFurther Information on US Private Placement
1st May 20142:12 pmRNSDirector Dealings
30th Apr 20144:48 pmRNSResult of AGM
30th Apr 20148:27 amRNSTotal Voting Rights
30th Apr 20147:01 amRNSAppointment of Chairman
28th Apr 20147:00 amRNSInterim Management Statement
24th Apr 20144:43 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSAnnual Financial Report
21st Mar 201411:12 amRNSAdditional Listing
17th Mar 20142:54 pmRNSHolding(s) in Company
10th Mar 201410:54 amRNSHolding(s) in Company
10th Mar 201410:26 amRNSHolding(s) in Company
5th Mar 20144:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.